BIO: Digital PCR growth, operational efficiency, and R&D focus drive long-term margin expansion
Q2 saw sequential improvement, with digital PCR and APAC strength offsetting softness in A&G and China. Guidance anticipates flat Q3 and a modest Q4 ramp, driven by quality controls and blood typing. Operational efficiency, R&D reprioritization, and AI adoption underpin long-term growth and margin…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.